🇺🇸 FDA
Drug

levodopa

Brand: INBRIJA

approved

Quick answer

levodopa (INBRIJA), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
levodopa
Brand
INBRIJA
Route
ORAL
Formulation
POWDER

Related patents

patent

US 12370163

Levodopa dosing regimen

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12303481

Levodopa dosing regimen

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12303482

Levodopa dosing regimen

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12295931

Levodopa dosing regimen

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12263149

Levodopa dosing regimen

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12263148

Levodopa dosing regimen

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12201596

Levodopa dosing regimen

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12194150

Levodopa dosing regimen

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is levodopa?

levodopa (INBRIJA), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for levodopa?

INBRIJA is a marketed brand name for levodopa. Check FDA Drugs@FDA for the current US label holder.